Download PDF
Thromb Haemost 1974; 32(01): 071-078
DOI: 10.1055/s-0038-1647674
Original Article
Schattauer GmbH

On the Antithrombotic Action of Heparin[*]

Stanford Wessler
Department of Medicine, The Jewish Hospital of St. Louis and the Washington University School of Medicine, St. Louis, Missouri, U.S.A
,
E Thye Yin
Department of Medicine, The Jewish Hospital of St. Louis and the Washington University School of Medicine, St. Louis, Missouri, U.S.A
› Author Affiliations
Further Information

Publication History

Received 03 June 1974

Accepted after resubmission 03 June 1974

Publication Date:
30 June 2018 (online)

    Permissions and Reprints

 

* Presented at the American Society of Hematology Meeting, Chicago, December 1. 1973.


 

  • References

  • 1 Bauer G. 1954. Proceedings of the 1st International Conference on Thromboembolism. B. Schwabe; Basel: 721.
    Google Scholar
  • 2 Best C. H. 1948. In: Blood Clotting and Allied Problems. Josiah Jr M. a.cy. Foundation; New York: 26.
    Google Scholar
  • 3 Biggs R, Denson K WE, Akman N, Borrett R, Hadden M. 1970; Antithrombin III antifactor Xa and heparin. British Journal of Haematology 19: 283.
    CrossrefPubMedGoogle Scholar
  • 4 Detakats G. 1950; Anticoagulants in surgery. Journal of the American Medical Association 142: 527.
    CrossrefPubMedGoogle Scholar
  • 5 Deykin D. 1968; Hepatic removal of activated Factor X by the perfused rabbit liver. American Journal of Physiology 214: 414.
    PubMedGoogle Scholar
  • 6 Gurewich V, Thomas D. P, Stein M, Wessler S. 1963; Bronchoconstriction in the presence of pulmonary embolism. Circulation 27: 339.
    CrossrefPubMedGoogle Scholar
  • 7 Jevons S, Barton P. G. 1971; Biochemistry of blood platelets. I. Interaction of activated Factor X with platelets. Biochemistry (Seattle) 10: 428.
    PubMedGoogle Scholar
  • 8 Leggenhager K. 1957; Genese und Prophylaxis der postoperativen Fernthrombose. Helvetica chirurgica acta 24: 316.
    PubMedGoogle Scholar
  • 9 Marciniak E. 1973; Factor-Xa inactivation by antithrombin III. Evidence for biological stabilization of Factor Xa by Factor Y-phospholipid complex. British Journal of Haematology 24: 391.
    PubMedGoogle Scholar
  • 10 Marciniak E, Tsueamura S. 1972; Two progressive inhibitors of Factor Xa in human blood. British Journal of Haematology 22: 341.
    CrossrefPubMedGoogle Scholar
  • 11 Marcus A. J, Zucker M. B. 1965. The Physiology of Blood Platelets. Grune and Stratton. New York: 21.
    Google Scholar
  • 12 Rosenberg R. D, Damus Paul S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
    PubMedGoogle Scholar
  • 13 Seegers W. H. 1968; Antithrombin on proteinase inhibitor. Annals of the New York Academy of Sciences 146: 593.
    CrossrefPubMedGoogle Scholar
  • 14 Seegers W. H, Cole E. R, Hatmison C. R, Monkhouse F. C. 1964; Neutralization of autoprothrombin C activity with antithrombin. Canadian Journal of Biochemistry 42: 359.
    CrossrefPubMedGoogle Scholar
  • 15 Seegers W. H, Marciniak E. 1962; Inhibition of autoprothrombin C activity with plasma. Nature (Lond.) 193: 1188.
    PubMedGoogle Scholar
  • 16 Sharnoff J. G. 1966; Results in the prophylaxis of postoperative thromboembolism. Surgical Gynaecology and Obstetrics 123: 303.
    PubMedGoogle Scholar
  • 17 Spaet T. H, Kropatkin M. 1957; Effect of intrasinous soy bean phosphatides on blood coagulation in rabbits. Proceedings of the Society for Experimental Biology 95: 492.
    PubMedGoogle Scholar
  • 18 Surgenor D. M, Wallach D. F.H. 1961. Biophysical Aspects of Platelet Reaction Mechanisms in Clotting. In: Johnson S. A, Monto R. W, Rebuck J. W. , Horn Jr. R. C. (eds.) Blood Platelets, Little: Brown, Boston; 289.
    Google Scholar
  • 19 Thomas D. P, Stein M, Tanabe G, Rege V, Wessler S. 1964; Mechanism of bronchoconstriction produced by thromboemboli in dogs. American Journal of Pysio- logy 206: 1207.
    PubMedGoogle Scholar
  • 20 Thomas D. P, Wessler S. 1964; Stasis thrombi induced by bacterial endotoxin. Circulation Research 14: 486.
    CrossrefPubMedGoogle Scholar
  • 21 Wessler S. 1953; Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments. Journal of Clinical Investigation 32: 650.
    PubMedGoogle Scholar
  • 22 Wessler S, Fischbein J. W. 1954; An improved method for the intravenous administration of heparin: its clinical application. New England Journal of Medicine 250: 860.
    CrossrefPubMedGoogle Scholar
  • 23 Wessler S, Morris L. E. 1955; Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis. Circulation 12: 553.
    PubMedGoogle Scholar
  • 24 Wessler S, Yin E. T. 1973; The theory and practice of mini-dose heparin in surgical patients: a status report. Circulation 47: 671.
    CrossrefPubMedGoogle Scholar
  • 25 Yin E. T, Guidice L. C, Wessler S. 1973a Inhibition of activated Factor X- induced platelet aggregation : the role of heparin and the plasma inhibitor to activated Factor X. Journal of Laboratory and Clinical Medicine 81: 298.
    PubMedGoogle Scholar
  • 26 Yin E. T, Wessler S, Butler J. V. 1973b Plasma heparin: a unique practical, submicrogram-sensitive assay. Journal of Laboratory and Clinical Medicine 81: 298.
    PubMedGoogle Scholar
  • 27 Yin E. T, Wessler S. 1968; Investigation of the apparent thrombogenicity of thrombin. Thrombosis et Diathesis Haemorrhagica 20: 465.
    PubMedGoogle Scholar
  • 28 Yin E. T, Wessler S. 1969; Evidence for a naturally occurring plasma inhibitor of activated Factor X: its isolation and partial purification. Thrombosis et Diathesis Haemorrhagica 21: 398.
    PubMedGoogle Scholar
  • 29 Yin E. T, Wessler S. 1970; Heparin-accelerated inhibition of activated Factor X by its natural plasma inhibitor. Biochemica Biophysica Acta 201: 387.
    CrossrefPubMedGoogle Scholar
  • 30 Yin E. T, Wessler S, Stoll P. J. 1971a Biological properties of the naturally- occurring plasma inhibitor to activated Factor X. Journal of Biological Chemistry 246: 3703.
    PubMedGoogle Scholar
  • 31 Yin E. T, Wessler S, Stoll P. J. 1971b Identity of plasmaactivated Factor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry 246: 3712.
    PubMedGoogle Scholar
  • 32 Yin E. T, Wessler S, Stoll P. J. (1971 c) Rabbit plasma inhibitor of the activated species of blood coagulation Factor X. Purification and some properties. Journal of Biological Chemistry 246: 3694.
    PubMedGoogle Scholar